|
SF3B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.558700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.084100E-03 |
| Normal-vs-Stage2 |
4.91359999998942E-06 |
| Normal-vs-Stage3 |
3.75260000000655E-05 |
| Normal-vs-Stage4 |
2.899400E-03 |
| Stage1-vs-Stage2 |
6.902700E-03 |
| Stage1-vs-Stage3 |
2.541900E-02 |
| Stage1-vs-Stage4 |
4.533000E-01 |
| Stage2-vs-Stage3 |
3.067200E-01 |
| Stage2-vs-Stage4 |
8.441800E-02 |
| Stage3-vs-Stage4 |
3.562000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.234300E-04 |
| Normal-vs-AfricanAmerican |
2.337400E-01 |
| Normal-vs-Asian |
7.363800E-02 |
| Caucasian-vs-AfricanAmerican |
2.842600E-01 |
| Caucasian-vs-Asian |
3.321600E-01 |
| AfricanAmerican-vs-Asian |
7.744200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.002000E-04 |
| Normal-vs-Female |
5.353200E-04 |
| Male-vs-Female |
9.797800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.047500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.990800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.69321999999861E-05 |
| Normal-vs-Age(81-100Yrs) |
1.885530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.062300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.379700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.645000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.840840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.145200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.903400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.255800E-02 |
| Classical-VS-Follicular |
1.78740000023048E-07 |
| Classical-VS-Other |
4.850600E-01 |
| Classical-VS-Normal |
2.733500E-02 |
| Tall-VS-Follicular |
2.313800E-01 |
| Tall-VS-Other |
5.962000E-01 |
| Tall-VS-Normal |
3.377800E-04 |
| Follicular-VS-Other |
3.505600E-01 |
| Follicular-VS-Normal |
3.04169999965076E-07 |
| Other-VS-Normal |
1.158570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71243000000043E-05 |
| Normal-vs-N1 |
1.378610E-01 |
| N0-vs-N1 |
1.514260E-02 |
|
|
